Sint Maartenskliniek Stichting

6 trials 3 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

3 Completed trials

1 Countries active

10 Unique IMPs

100% Results reported

Phase III

Phase IV

Phase III: 2 Phase IV: 4

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Polymyalgia rheumatica 2 Gout 1

Top IMPs

BARICITINIB 1 COLCHICINE 1 FILGOTINIB 1 METHYLPREDNISOLONE ACETATE 1 SODIUM CHLORIDE 1 TOFACITINIB 1 UPADACITINIB 1

All trials

6 total

The efficacy and safety of Intramuscular Methylprednisolone in patients with Hand OsteoArthritis: the IMHOA trial Recruiting

2024-518344-20-00 Phase III 1 country METHYLPREDNISOLONE ACETATE; SODIUM CHLORIDE
REDO-JAK: Dose REDuction Of JAnus Kinase inhibitors in patients with inflammatory rheumatic diseases Recruiting

2025-520757-36-00 Phase IV 1 country BARICITINIB; FILGOTINIB; TOFACITINIB; UPADACITINIB
Colchicine for the treatment of hip and knee osteoarthritis. Recruiting

2024-511359-16-00 Phase III 1 country COLCHICINE
REDUCE PMR: Rituximab Effect on Decreasing glUcoCorticoid Exposition in relapsing PolyMyalgia Rheumatica Ended

2024-513545-37-00 Phase IV 1 country
GO TEST FINALE Ended

2024-511111-13-01 Phase IV 1 country
REDUCE PMR: Rituximab Effect on Decreasing glUcoCorticoid Exposition in newly diagnosed PolyMyalgia Rheumatica Ended

2024-513544-28-00 Phase IV 1 country

Showing 1–6 of 6 trials

← All sponsors A–Z